Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Synectics appoints Dr Kerstin Wendt

1 Dec 2020 07:00

RNS Number : 9909G
Synectics PLC
01 December 2020
Β 

RNS Reach 1 December 2020

Β 

Synectics plc

("Synectics" or the "Company" or the "Group")

Β 

Synectics appoints Dr Kerstin Wendt to head its German Operations

Β 

Synectics plc (AIM: SNX): Synectics has appointed Dr Kerstin Wendt to lead its growing German business with major public transport operators. Dr Wendt will be based in Synectics' new Berlin office as the business brings its German operations closer to key customer locations.

Β 

Dr Wendt becomes part of the Synectics team following 13 years in public transport operations and transportation technology businesses. In her new role, she will lead implementation of Synectics' next-generation operational management system for S-Bahn Berlin (a subsidiary of Deutsche Bahn) and head up the relationship with long-term U-Bahn client Berliner Verkehrsbetriebe (BVG).

Β 

Commenting on the appointment, Greg Alcorn, Director of Global Sales and Customer Success at Synectics commented: "I am delighted to welcome Kerstin to the business as we drive ahead with strategically important urban transport projects and customers.

Β 

"Kerstin is ideally positioned to develop our German business. Her experience within the urban transport industry and knowledge of digital technology in transport operations, will enable our clients to maximise their investment in our software solutions.

Β 

"At the same time, she will play a key role as we open up new opportunities for the innovative security and operations management solution we are implementing for S-Bahn Berlin as part of its new Security and Service (4S) Center development. New collaborative applications for workforce management with interactive mobile capabilities are set to transform the capability and reach of urban transport control room operations."

Β 

Dr Wendt joins Synectics from VBB (Verkehrsverbund Berlin-Brandenburg) where she led the development of fares and digital ticketing for the Berlin-Brandenburg urban transport network. Before VBB, Dr Wendt was part of IVU Traffic Technologies, working on a range of passenger information, fleet management and digital ticketing projects in the DACH (Austria, Germany, and Switzerland) region.

Β 

/Ends

Β 

About Synectics plc

Β 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

Β 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

Β 

Find out more at www.synecticsplc.com

Β 

Β 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Paul Webb, Chief Executive

David Bedford, Finance Director

Helen Kettleborough, Global Marketing & Communications Director

email: info@synecticsplc.com

www.synecticsplc.com

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / Henry Willcocks / David Coaten

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAWPGAWGUPUGQU
Date   Source Headline
22nd Jun 20263:14 pmRNSEBT Share Purchase
18th Jun 20267:00 amRNSNew Stagecoach Orders Totalling £1.5m
15th Jun 20263:44 pmRNSEBT Share Purchase
12th Jun 20263:54 pmRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSEBT Share Purchase
1st Jun 20261:48 pmRNSEBT Share Purchase
20th May 20267:00 amRNSFunding of EBT to Acquire Ordinary Shares and RPT
18th May 202612:48 pmRNSResult of AGM
18th May 20267:01 amRNSBoard Change
18th May 20267:00 amRNSAGM Trading Update
23rd Apr 20261:30 pmRNSCorrection to Notice of Annual General Meeting
14th Apr 20267:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
13th Mar 20262:05 pmRNSDirector dealings
12th Mar 20267:00 amRNSDirector Dealings
9th Mar 202610:20 amRNSDirector Dealings
3rd Mar 20263:30 pmRNSDirector / PCA Dealings
3rd Mar 20267:00 amRNSFinal Results and Strategic Update
24th Feb 202612:15 pmRNSNotice of Final Results and Investor Presentation
23rd Feb 20267:00 amRNSOngoing New Business Momentum
19th Feb 20261:41 pmRNSHolding(s) in Company
19th Jan 20269:00 amRNSHoldings in Company
18th Dec 202510:00 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSFull Year Trading Update
24th Nov 20257:00 amRNS-RExtension of Framework Agreement with Stagecoach
3rd Nov 20257:00 amRNS£1.8 million contract with Bus Eireann
16th Oct 20257:01 amRNSNew Contracts - Traction in Broader Energy Sector
16th Oct 20257:01 amRNSTrading Update
16th Oct 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
9th Oct 202512:16 pmRNSDirector dealings
2nd Oct 20257:00 amRNSPDMR dealings
2nd Sep 20257:00 amRNSDirector/PDMR Shareholding
29th Aug 20257:00 amRNSPDMR dealings
16th Jul 20257:00 amRNSLeisure & Hospitality Contract Wins
8th Jul 20257:00 amRNSHalf-year Report
19th Jun 20257:00 amRNSAppointment of Chief Financial Officer
9th Jun 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNSUS$4.8m Contract Extension
21st May 20257:00 amRNSPDMR Dealings
12th May 20257:00 amRNS£1.1 million Contract Award
7th May 20251:00 pmRNSResult of Annual General Meeting
7th May 20257:00 amRNSAGM Trading Update
2nd Apr 20257:00 amRNSPDMR dealings
1st Apr 20257:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
31st Mar 20257:00 amRNS£2.0 million Award
4th Mar 20257:00 amRNSFinal Results
14th Feb 20257:00 amRNSNotice of Final Results and Investor Presentation
27th Jan 20257:00 amRNS$2.2 million Contract Award
13th Jan 20255:30 pmRNSHoldings in Company
6th Jan 20258:40 amRNSHoldings in Company
6th Jan 20258:30 amRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.